Press Release Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Jul 20
Press Release Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome Jul 14